Australia's most trusted
source of pharma news
Tuesday, 22 October 2024
Posted 22 October 2024 AM
An analysis of the 2024 respiratory illness season has highlighted the need for a national immunisation strategy covering older Australians.
Moderna's winter report card found that around 160,490 out of 744,000 - or one fifth - of laboratory-confirmed cases of vaccine-preventable viral respiratory infections reported were in adults 65 years and older.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.